Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. […]
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Circassia and is included in one NDA.
Patent delisted for Circassia drug TUDORZA PRESSAIR Read Post »
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one
Patent delisted for Purdue Pharma drug OXYCONTIN Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug TRADJENTA Read Post »
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs.
Patent delisted for Boehringer Ingelheim drug JENTADUETO Read Post »
Get fresh news and insights, drug patent expirations & more…
